查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1513432

美國嬰幼兒益生菌市場規模、佔有率、競爭格局、按年齡層、產品類型和分銷管道的趨勢分析報告：2023年至2032年全球市場機會分析和行業預測

U.S. Infant and Kids Probiotics Market Size, Share, Competitive Landscape and Trend Analysis Report by Age Group, Product Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2022年美國嬰幼兒益生菌市場價值為1.5924億美元，預計2032年將達到3.7089億美元，2023年至2032年複合年成長率為9.1%，創歷史新高。

嬰兒益生菌是含有有益細菌菌株的專門補充品，通常適合 0 至 12 個月大的嬰兒。這些製劑旨在支持消化器官系統健康、增強免疫系統並緩解絞痛和尿布疹等問題。它們通常含有嬰兒雙叉桿菌和鼠李糖乳桿菌等菌株，這些菌株對嬰兒敏感的腸道菌叢友好且有益。兒童益生菌適合 1 歲及以上兒童，並提供類似的益處，但使用適合年齡較大兒童需求的菌株，促進整體健康並幫助消化。這兩種類型的益生菌都有多種形式，包括滴劑、粉末和錠劑，方便父母服用。美國嬰兒消化器官系統疾病的發生率迅速增加，是該族群對益生菌需求的主要驅動力。絞痛、便秘、腹瀉和大腸激躁症(IBS) 等消化器官系統問題在幼兒中越來越常見，影響著他們的整體健康和生活品質。由於傳統治療方法可能會給嬰兒帶來風險和不良副作用，益生菌提供了安全、天然的替代方案。益生菌含有有益細菌，有助於恢復腸道菌叢平衡，強化消化器官系統，緩解各種消化系統疾病的症狀。人們越來越認知到益生菌在管理消化器官系統問題方面的潛在益處，這推動了美國市場對嬰兒和兒童益生菌的需求。此外，醫療保健專業人士也擴大推薦益生菌作為管理嬰兒和兒童消化器官系統健康的整體方法的一部分，這將進一步促進未來幾年的市場成長。可用的益生菌菌株數量眾多，而且不同產品的配方和劑量各不相同，使得消費者和醫療保健提供者很難確定哪些產品最適合和有效地滿足他們面臨的特定健康需求。此外，缺乏嬰兒和兒童使用益生菌的標準化指南使問題更加複雜。如果沒有醫療專業人士的明確建議，父母可能不願意將益生菌納入孩子的日常保健中，因為擔心潛在的副作用或無效的結果。缺乏指導限制了市場的採用，並阻止益生菌充分發揮其解決兒科消化器官系統健康問題的潛力。為了克服這一抑制因素並增強消費者和醫療保健提供者對美國嬰兒和兒童益生菌市場的信心，需要製定關於益生菌菌株、配方、劑量和建議劑量的明確指南，包括制定標準。隨著益生菌產品在家長中越來越受歡迎和需求不斷成長，利用多元化的分銷管道覆蓋更廣泛的消費者群體非常重要。除了傳統的實體店外，線上平台還為父母為孩子購買益生菌提供了一種方便快捷的方式，適應忙碌的生活方式並避免地域限制，您可以接觸到更廣泛的消費者。此外，與醫院、小兒科診所、生育中心等醫療機構合作可以加強益生菌產品的供應。醫療保健提供者在教育家長了解益生菌的好處並為孩子推薦合適的產品方面發揮著重要作用。此外，透過與藥局和保健食品商店合作，我們可以提高嬰兒和兒童益生菌的認知度和可用性，以便消費者在購買其他保健必需品的同時可以輕鬆找到和購買。製造商和零售商可以利用多元化的分銷管道來滿足嬰幼兒益生菌不斷成長的需求，擴大市場覆蓋範圍並推動美國市場的成長。此外，策略行銷工作以及與相關人員的合作可以提高人們對幼兒腸道環境的重要性和益生菌的作用的認知，透過各種分銷管道進一步刺激需求，可以促進市場擴張。格柏產品公司和 BioGaiai 等領先公司正在做出重大改變，以產品推出其產品系列，並在美國嬰幼兒益生菌市場上站穩腳跟。例如，2020年4月，格柏Goodstart推出了獨特的A2嬰兒營養系列，以加強產品系列。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 市場動態
    • 促進因素
      • 增加益生菌的創新
      • 千禧世代的父母越來越注重健康
    • 抑制因素
      • 消費者對益生菌產品的功效缺乏認知
      • 益生菌監理不足
    • 機會
      • 益生菌市場在線快速滲透
    • 任務
      • 加工和保存期限要求
  • 益生菌市場通路動態
  • 消費者購買趨勢

第4章美國嬰幼兒益生菌市場：依形式

  • 概述
  • 液體
    • 主要市場趨勢、成長要素與機遇
  • 粉末
    • 主要市場趨勢、成長要素與機遇
  • 可咀嚼的
    • 主要市場趨勢、成長要素與機遇
  • 其他
    • 主要市場趨勢、成長要素與機遇

第5章美國嬰幼兒益生菌市場：依通路分類

  • 概述
  • 零售藥局/藥局
    • 主要市場趨勢、成長要素與機遇
  • 百貨公司
    • 主要市場趨勢、成長要素與機遇
  • 超級市場/大賣場
    • 主要市場趨勢、成長要素與機遇
  • 電子商務
    • 主要市場趨勢、成長要素與機遇

第6章美國嬰幼兒益生菌市場：依年齡段

  • 概述
  • 嬰兒
    • 主要市場趨勢、成長要素與機遇
  • 孩子
    • 主要市場趨勢、成長要素與機遇

第7章 競爭格局

  • 益生菌銷售前10名SKU（2019年）
  • 競爭對手的市場佔有率分析（2019）
    • i-Health, Inc.
      • i-Health, Inc：公司簡介
    • Gerber
      • 格柏：公司簡介
    • LoveBug Probiotics
      • LoveBug 益生菌：公司簡介
    • Mommy's Bliss Inc.
      • Mommy's Bliss Inc.：公司簡介
    • Zarbees, Inc.
      • Zarbees, Inc.：公司簡介
    • FIT-BioCeuticals Ltd
      • FIT-BioCeuticals 有限公司：公司簡介
    • Florastor
      • Florastor：公司簡介
    • BioGaia
      • BioGaia：公司簡介
    • Mama's Select
      • 媽媽的選擇：公司簡介
    • Hyperbiotics
      • Hyperbiotics：公司簡介
Product Code: A06112

The U.S. infant and kids probiotics market was valued at $159.24 million in 2022 and is projected to reach $370.89 million by 2032, registering a CAGR of 9.1% from 2023 to 2032.Infant probiotics are specialized supplements containing beneficial bacteria strains suitable for infants, typically aged 0 to 12 months. These formulations aim to support digestive health, strengthen the immune system, and alleviate issues like colic or diaper rash. They often contain strains such as Bifidobacterium infantis or Lactobacillus rhamnosus, which are gentle and beneficial for sensitive infant gut microbiota. Kids' probiotics cater to children above one year old, offering similar benefits but with strains tailored to older children's needs, promoting overall well-being and aiding digestion. Both types of probiotics come in various forms like drops, powders, or chewable tablets, ensuring easy administration for parents.The surge in digestive disorders among infants and children in the United States has become a significant driver propelling the demand for probiotics in this demographic. Digestive issues such as colic, constipation, diarrhea, and irritable bowel syndrome (IBS) are increasingly common among young children, impacting their overall well-being and quality of life. Parents and caregivers are seeking effective solutions to alleviate these discomforts and promote better digestive health for their little ones.As conventional treatments may pose risks or unwanted side effects in infants and young children; probiotics offer a safe and natural alternative. Probiotics contain beneficial bacteria that can help restore the balance of the gut microbiota, strengthen the digestive system, and alleviate symptoms of various digestive disorders. This increased awareness of the potential benefits of probiotics in managing digestive issues has fueled the demand for infant and kids probiotics in the U.S. market. Moreover, healthcare professionals are also more frequently recommending probiotics as part of a holistic approach to managing digestive health in infants and children, further contributing to the market growth in coming years.However, the lack of standardization in the U.S. infant and kids probiotics market poses a significant restraint on market demand. With numerous probiotic strains available and varying formulations and dosages across products, consumers and healthcare providers face challenges in determining which products are most suitable and effective for specific health needs. The lack of consistency leads to confusion and hesitation among consumers, ultimately hindering market growth as parents may opt for alternative remedies or traditional healthcare approaches.Furthermore, the absence of standardized guidelines for probiotic usage in infants and children exacerbates the issue. Without clear recommendations from healthcare professionals, parents may be reluctant to incorporate probiotics into their children's healthcare routine, fearing potential adverse effects or ineffective outcomes. This lack of guidance limits market adoption and prevents probiotics from reaching their full potential in addressing pediatric digestive health issues. Standardization efforts, including the establishment of clear guidelines for probiotic strains, formulations, dosages, and usage recommendations, are crucial to overcoming this restraint and fostering confidence among consumers and healthcare providers in the U.S. infant and kids probiotics market.The expansion of distribution channels presents significant opportunities in the U.S. infant and kids probiotics market. With the increasing popularity and demand for probiotic products among parents, leveraging a diverse range of distribution channels becomes crucial for reaching a wider consumer base. Beyond traditional brick-and-mortar stores, online platforms offer a convenient and accessible avenue for parents to purchase probiotics for their children, catering to busy lifestyles and providing a broader reach to consumers across geographical locations. Moreover, partnerships with healthcare institutions such as hospitals, pediatric clinics, and birthing centers can enhance the availability of probiotic products, as healthcare providers play a crucial role in educating parents about the benefits of probiotics and recommending suitable products for their children.Furthermore, collaboration with pharmacies and health food stores can increase the visibility and accessibility of infant and kids probiotics, allowing consumers to easily find and purchase these products while shopping for other healthcare essentials. By tapping into a diverse array of distribution channels, manufacturers and retailers can capitalize on the growing demand for infant and kids probiotics, expanding market reach, and driving growth in the U.S. market. Moreover, strategic marketing efforts and partnerships with key stakeholders can help raise awareness about the importance of early childhood gut health and the role of probiotics, further fueling demand and driving market expansion through various distribution channels.The major players such as Gerber Products Company, and BioGaiai have adopted product launch as their key developmental strategy to improve their product portfolio and gain a strong foothold in the U.S. infant and kids probiotics market. For instance, in April 2020, Gerber Good Start introduced a unique A2 Infant and Toddler Nutrition range to strengthen its product portfolio in innovative probiotic products.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings
    • 2.1.1. Top investment pockets
  • 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Market dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Increase in innovations in probiotics
      • 3.2.1.2. Rise in health consciousness among millennial parents
    • 3.2.2. Restraints
      • 3.2.2.1. Lack of awareness among consumers regarding the effectiveness of probiotic products
      • 3.2.2.2. Inadequate regulation of probiotics
    • 3.2.3. Opportunities
      • 3.2.3.1. Surge in online penetration of probiotic market
    • 3.2.4. Challenges
      • 3.2.4.1. Processing and shelf life requirements
  • 3.3. Probiotics Market: Channel Dynamics
  • 3.4. Consumer buying trends

CHAPTER 4: U.S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM

  • 4.1. Overview
  • 4.2. Liquid
    • 4.2.1. Key market trends, growth factors, and opportunities
  • 4.3. Powder
    • 4.3.1. Key market trends, growth factors, and opportunities
  • 4.4. Chewable
    • 4.4.1. Key market trends, growth factors, and opportunities
  • 4.5. Other
    • 4.5.1. Key market trends, growth factors, and opportunities

CHAPTER 5: U.S. INFANT AND KIDS PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Overview
  • 5.2. Retail Pharmacies/Drug Stores
    • 5.2.1. Key market trends, growth factors, and opportunities
  • 5.3. Departmental Stores
    • 5.3.1. Key market trends, growth factors, and opportunities
  • 5.4. Supermarket/Hypermarket
    • 5.4.1. Key market trends, growth factors, and opportunities
  • 5.5. E-commerce
    • 5.5.1. Key market trends, growth factors, and opportunities

CHAPTER 6: U.S. INFANT AND KIDS PROBIOTICS MARKET, BY AGE GROUP

  • 6.1. Overview
  • 6.2. Baby/Infant
    • 6.2.1. Key market trends, growth factors, and opportunities
  • 6.3. Kids
    • 6.3.1. Key market trends, growth factors, and opportunities

CHAPTER 7: COMPETITION LANDSCAPE

  • 7.1. Probiotics revenue by top 10 SKU (2019)
  • 7.2. Market share analysis by competitor (2019)
    • 7.2.1. i-Health, Inc. (Culturelle)
      • 7.2.1.1. i-Health, Inc. (Culturelle): Company Overview
    • 7.2.2. Gerber
      • 7.2.2.1. Gerber: Company Overview
    • 7.2.3. LoveBug Probiotics
      • 7.2.3.1. LoveBug Probiotics: Company Overview
    • 7.2.4. Mommy's Bliss Inc.
      • 7.2.4.1. Mommy's Bliss Inc. : Company Overview
    • 7.2.5. Zarbees, Inc.
      • 7.2.5.1. Zarbees, Inc. : Company Overview
    • 7.2.6. FIT-BioCeuticals Ltd
      • 7.2.6.1. FIT-BioCeuticals Ltd: Company Overview
    • 7.2.7. Florastor
      • 7.2.7.1. Florastor: Company Overview
    • 7.2.8. BioGaia
      • 7.2.8.1. BioGaia: Company Overview
    • 7.2.9. Mama's Select
      • 7.2.9.1. Mama's Select: Company Overview
    • 7.2.10. Hyperbiotics
      • 7.2.10.1. Hyperbiotics: Company Overview

LIST OF TABLES

  • TABLE 01. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM, 2018-2026 ($MILLION)
  • TABLE 02. U.S. INFANT AND KIDS PROBIOTICS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017-2026 ($MILLION)
  • TABLE 03. U.S. INFANT AND KIDS PROBIOTICS MARKET REVENUE, BY AGE GROUP, 2018-2026 ($MILLION)

LIST OF FIGURES

  • FIGURE 01. KEY MARKET SEGMENTS
  • FIGURE 02. EXECUTIVE SUMMARY
  • FIGURE 03. TOP INVESTMENT POCKETS
  • FIGURE 04. MARKET DYNAMIC ANALYSIS
  • FIGURE 05. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM, 2018
  • FIGURE 06. LIQUID PROBIOTICS MARKET, 2018-2026 ($MILLION)
  • FIGURE 07. POWDER PROBIOTICS MARKET, 2018-2026 ($MILLION)
  • FIGURE 08. CHEWABLE PROBIOTICS MARKET, 2018-2026 ($MILLION)
  • FIGURE 09. OTHER PROBIOTICS MARKET, 2018-2026 ($MILLION)
  • FIGURE 10. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2026
  • FIGURE 11. RETAIL PHARMACIES/DRUG STORES, 2018-2026 ($MILLION)
  • FIGURE 12. DEPARTMENTAL STORES, 2018-2026 ($MILLION)
  • FIGURE 13. SUPERMARKET/HYPERMARKET, 2018-2026 ($MILLION)
  • FIGURE 14. E-COMMERCE, 2018-2026 ($MILLION)
  • FIGURE 15. U.S. INFANT AND KIDS PROBIOTICS MARKET, BY AGE GROUP, 2018-2026
  • FIGURE 16. BABY/INFANTS PROBIOTICS MARKET, 2018-2026 ($MILLION)
  • FIGURE 17. KIDS PROBIOTICS MARKET, 2018-2026 ($MILLION)